Ocugen, Inc. (BMV:OCGN)
Mexico flag Mexico · Delayed Price · Currency is MXN
15.20
0.00 (0.00%)
Last updated: May 12, 2025

Ocugen Statistics

Total Valuation

Ocugen has a market cap or net worth of MXN 4.01 billion. The enterprise value is 3.90 billion.

Market Cap 4.01B
Enterprise Value 3.90B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date May 9, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 292.01M
Shares Outstanding n/a
Shares Change (YoY) +10.88%
Shares Change (QoQ) +0.37%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 287.37M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 43.43
PB Ratio 12.34
P/TBV Ratio 12.34
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.32
EV / Sales 43.88
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -3.67

Financial Position

The company has a current ratio of 2.60, with a Debt / Equity ratio of 2.00.

Current Ratio 2.60
Quick Ratio 2.24
Debt / Equity 2.00
Debt / EBITDA n/a
Debt / FCF -0.61
Interest Coverage -62.41

Financial Efficiency

Return on equity (ROE) is -248.97% and return on invested capital (ROIC) is -84.05%.

Return on Equity (ROE) -248.97%
Return on Assets (ROA) -61.33%
Return on Invested Capital (ROIC) -84.05%
Return on Capital Employed (ROCE) -119.90%
Revenue Per Employee 972,892
Profits Per Employee -12.37M
Employee Count 95
Asset Turnover 0.08
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -47.86% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -47.86%
50-Day Moving Average 13.54
200-Day Moving Average 18.56
Relative Strength Index (RSI) 67.50
Average Volume (20 Days) 43

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 18.26

Income Statement

In the last 12 months, Ocugen had revenue of MXN 92.42 million and -1.18 billion in losses. Loss per share was -4.20.

Revenue 92.42M
Gross Profit -571.17M
Operating Income -1.17B
Pretax Income -1.17B
Net Income -1.18B
EBITDA -1.11B
EBIT -1.17B
Loss Per Share -4.20
Full Income Statement

Balance Sheet

The company has 772.59 million in cash and 650.43 million in debt, giving a net cash position of 122.16 million.

Cash & Cash Equivalents 772.59M
Total Debt 650.43M
Net Cash 122.16M
Net Cash Per Share n/a
Equity (Book Value) 325.26M
Book Value Per Share 1.11
Working Capital 553.44M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.04 billion and capital expenditures -21.44 million, giving a free cash flow of -1.06 billion.

Operating Cash Flow -1.04B
Capital Expenditures -21.44M
Free Cash Flow -1.06B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,261.43%
Pretax Margin -1,271.12%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Ocugen does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.88%
Shareholder Yield -10.88%
Earnings Yield -29.28%
FCF Yield -26.45%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Ocugen has an Altman Z-Score of -6.21. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.21
Piotroski F-Score n/a